SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001516551-22-000028
Filing Date
2022-08-31
Accepted
2022-08-31 17:19:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFM14A skyebioscienceincproxydef.htm DEFM14A 4731099
2 GRAPHIC image1a.jpg GRAPHIC 8359
3 GRAPHIC image_01a.jpg GRAPHIC 29243
4 GRAPHIC image_0a.jpg GRAPHIC 25243
5 GRAPHIC imagea.jpg GRAPHIC 1083
6 GRAPHIC picture1a.jpg GRAPHIC 4869
7 GRAPHIC skye-xlogoxxblacka.jpg GRAPHIC 208624
8 GRAPHIC skyeproxycardproof4_2a.jpg GRAPHIC 176150
9 GRAPHIC skyeproxycardproof4a.jpg GRAPHIC 121952
  Complete submission text file 0001516551-22-000028.txt   5525337
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-55136 | Film No.: 221218810
SIC: 2834 Pharmaceutical Preparations